Chemed Reports Q2 Adjusted EPS $4.60.

CHEMED REPORTS SECOND-QUARTER 2021 RESULTS - FULL-YEAR 2021 GUIDANCE INCREASED.
SEES FY ADJUSTED EARNINGS PER SHARE $18.20 TO $18.50 EXCLUDING ITEMS.Q2 ADJUSTED EARNINGS PER SHARE $4.60.
Q2 GAAP EARNINGS PER SHARE $3.51.
Q2 EARNINGS PER SHARE ESTIMATE $4.29 -- REFINITIV IBES DATA.
QTRLY REVENUE INCREASED 6.0% TO $532 MILLION.
FY2021 EARNINGS PER SHARE VIEW $17.35 -- REFINITIV IBES DATA.
Q2 REVENUE VIEW $511.9 MILLION -- REFINITIV IBES DATA.